SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Sioux Nation -- Ignore unavailable to you. Want to Upgrade?


To: T L Comiskey who wrote (13415)4/14/2005 10:38:13 AM
From: James Calladine  Read Replies (1) | Respond to of 361059
 
YOU ASKED--HERE'S A SNIPPET OF A REPLY:
(a small part of a spontaneously given talk)

ADI DA SAMRAJ: "Have you all heard about the Dreaded Gom-Boo? Or the impossible Three-Day Thumb-and-Finger Problem? Ah ha! You see? Nobody tells you about these things except me.

A myth has been circulating for many centuries now that mankind is diseased, that all beings are suffering from what I call the Dreaded Gom-Boo, also called sin, maya, ego, suffering, separated individuality, illusions, delusion, confusion, and indifference. We are all supposed to accept this diagnosis, realize how diseased we are, and submit ourselves to the local religious hospital, where a father or mother doctor will confirm our disease and require us to submit for the rest of our lives to various regimes for our own healing and ultimate cure. This is the basic proposition of traditional religion, and it begins with the diagnosis of the dreaded disease.

Tradition has it that we are all, by birth, by virtue of our very existence, even now diseased, sinful, separated from the Great One. What a horror! Yes! What an obscenity has been laid upon us through the traditions of society, which, merely because of the impulse to survive as the body-mind, have for centuries required human beings to invest themselves with the belief in this disease and to suppress their own life-motion, which comes only from the Great-One, in order to fulfill the presumed needs of our chaotic society.

I come to tell you, as I stand in the midst of the priests of this horror, that not even one of you is suffering from this disease. It is an imaginary disease, a terrible disease, but altogether imaginary. No one has ever actually had this disease. No one single being has ever had the Dreaded Gom-Boo, or the impossible thumb-and-finger problem. It has never happened! It does not exist!

What is the Truth? We are Happy. We live in God. The Great One is our very Being. We inhere in the Blissful, Forceful Being of the Starry God, the Wonder, the Mystery, the Person of Love. This is our Situation and our Destiny. I am only one among many voices, but this is my Message to you: There is no disease. There is nothing to cure. We are not patients and we are not parented. We are not children. No dreadful destiny.

How do you contract this imaginary disease and become involved in seeking its imaginary cure? I call you to observe yourself, and you will see, you're grabbing your ass! You are pinching your belly, you're causing yourself great pain because of your motive to be independent.

You will never be independent. There is not even a molecule of wood in this wall that is independent. Nothing and no one is independent. All of us inhere in the Great One, the Wonderful Lord, the Marvelous Starry Person, the Delight of Being. All of us live in That. That is our situation now. This moment is the moment of Happiness, as is every future moment, every moment after death, beyond this world and other worlds, higher worlds, after worlds, no worlds. It is all the moment of infinite Delight, unless we become self-conscious and withdraw from our relations and contract upon our Happiness and forget It."

Website at:

adidam.org

DISCLAIMER: I have been a devotee of Adi Da for 20 years and have spent hundreds of hours in his personal company. In my estimation, at the very least he is a wide-ranging genius far exceeding anything previously seen in this world. In actuality, he is much more than that. But as stated, I have my own bias.
However, I spent 20 years LOOKING FOR such a Teacher, before becoming his devotee, so he wasn't just a casual discovery.

Namaste!

Jim



To: T L Comiskey who wrote (13415)4/14/2005 10:48:09 AM
From: Wharf Rat  Read Replies (2) | Respond to of 361059
 
Anheuser-Busch Threatens Mo. Rice Boycott

Tue Apr 12, 5:20 PM ET Business - AP


By SAM HANANEL, Associated Press Writer

WASHINGTON - Anheuser-Busch Cos., the nation's No. 1 buyer of rice as well as its largest brewer, says it won't buy rice from Missouri if genetically modified, drug-making crops are allowed to be grown in the state.



The St. Louis-based beer giant, which says it is concerned about possible contamination, is the latest company to express concern over plans by Ventria Biosciences to grow 200 acres of rice engineered to produce human proteins that can make drugs.

Biotechnology firms have been seeking federal approval for outdoor plantings, often called "biopharming" because the idea is to lower drug-making costs by using plants to grow medications.

Other food companies, environmentalists and farmers have said they fear genetically altered rice could cross-pollinate with other food crops, introducing the foreign genes into the regular food chain.

Last month, Arkansas-based Riceland Foods Inc., the world's largest rice miller and marketer, asked federal regulators to deny a permit for Ventria's project, saying its customers don't want to risk buying genetically modified rice. Anheuser-Busch is believed to be the first major company to threaten a boycott over the issue, according to comments filed last month with the Agriculture Department.

"Given the potential for contamination of commercial rice production in this state, we will not purchase any rice produced or processed in Missouri if Ventria introduces its pharma rice here," Jim Hoffmeister, a vice president at Anheuser-Busch, said Tuesday.

Scott Deeter, president of Sacramento-based Ventria, called Anheuser-Busch's threat "totally irresponsible" and said fears of contamination are overblown. He cited Ventria's plans to use "a totally closed system of production" with a plant that pollinates itself and is separated geographically from any other crop.

Biopharming has been growing for a decade despite continued attacks from genetic engineering foes who fear such work has not been studied enough to ensure the safety of the nation's food supply if accidental mixing occurs.

Genetically modified crops are regulated by the USDA, with state governments allowed to review safety procedures and suggest more stringent regulation of the companies before a permit is issued.

Ventria is seeking USDA approval to grow rice genetically enhanced with synthetic human genes to produce the proteins lactoferrin and lysozyme, which the company hopes to harvest and refine for use in medicines to fight diarrhea and dehydration. The USDA can either deny Ventria's permit or issue a permit with additional conditions.

Since 1995, the USDA has approved more than 300 biopharming plantings around the country, though most are for small outdoor plots of less than acre each. If Ventria's application is approved, it would be the largest such growth site to date, USDA spokeswoman Karen Eggert said. No human drug made from genetically engineered crops has been approved for commercial use.

The issue has already roiled California's $500 million-a-year rice industry. Last year, California regulators denied Ventria's application to grow commercial quantities of rice with human genes after rice growers said they feared international customers would refuse to buy conventionally grown crops out of contamination fears.

Meanwhile, farmers in southeast Missouri, where nearly all of the state's $100 million rice crop is grown, have presented Missouri's agriculture director a petition with 175 signatures opposing the plans. Missouri is the sixth-largest rice-producing state.

Despite the concerns, the Missouri Farm Bureau has continued to support Ventria, which recently announced it was moving from Sacramento, Calif., to Northwest Missouri State University to be the anchor tenant of a new center for plant-made pharmaceuticals.

"Any concerns have been addressed thoroughly to the satisfaction of the scientific community," said university president Dean Hubbard.

In trading Tuesday, Anheuser-Busch shares rose 66 cents to $46.71 on the New York Stock Exchange. The stock has traded in a 52-week range of $45.45 to $54.74.

___
story.news.yahoo.com